The xc- cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases

Journal of Cellular Physiology

Volumn 215, Issue 3, 2008, Pages 593-602

  Lo, Maisie ^a,b   Wang, Yu Zhuo ^b,c   Gout, Peter W ^b,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

^d BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; ANTINEOPLASTIC AGENT; ANTIPORTER; ASPARAGINASE; CYSTEINE; CYSTINE; DOXORUBICIN; GELDANAMYCIN; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; GLUTATHIONE; SALAZOSULFAPYRIDINE;

CELL PROTECTION; EXCITOTOXICITY; GLUTATHIONE METABOLISM; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; TISSUE DISTRIBUTION; TUMOR GROWTH; ANIMAL; CHEMISTRY; METABOLISM; NEOPLASM;

HUMAN HERPESVIRUS 8;

AMINO ACID TRANSPORT SYSTEMS; ANIMALS; ANTIPORTERS; CYSTINE; GLUTAMIC ACID; HUMANS; NEOPLASMS;

EID: 42949126711     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21366     Document Type: Review

References (151)

1. Angelini G, Gardella S, Ardy M, Ciriolo MR, Filomeni G, Di Trapani G, Clarke F, Sitia R, Rubartelli A. 2002. Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc Natl Acad Sci USA 99:1491-1496.
2. Arlt A, Gehrz A, Muerkoster S, Vorndamm J, Kruse ML, Folsch UR, Schafer H. 2003. Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 22:3243-3251.
3. Augustin H, Grosjean Y, Chen K, Sheng Q, Featherstone DE. 2007. Nonvesicular release of glutamate by glial xCT transporters suppresses glutamate receptor clustering in vivo. J Neurosci 27:111-123.
4. Awasthi S, Sharma R, Singhal SS, Herzog NK, Chaubey M, Awasthi YC. 1994. Modulation of cisplatin cytotoxicity by sulphasalazine. Br J Cancer 70:190-194.
5. Baker DA, McFarland K, Lake RW, Shen H, Tang XC, Toda S, Kalivas PW. 2003. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci 6:743-749.
6. Bannai S. 1984a. Induction of cystine and glutamate transport activity in human fibroblasts by diethyl maleate and other electrophilic agents. J Biol Chem 259:2435-2440.
7. Bannai S. 1984b. Transport of cystine and cysteine in mammalian cells. Biochim Biophys Acta 779:289-306.
8. Bannai S. 1986. Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J Biol Chem 261:2256-2263.
9. Bannai S, Ishii T. 1988. A novel function of glutamine in cell culture: Utilization of glutamine for the uptake of cystine in human fibroblasts. J Cell Physiol 137:360-366.
10. Bannai S, Kasuga H. 1985. Anti-inflammatory drug inhibition of transport of cystine and glutamate in cultured human fibroblasts. Biochem Pharmacol 34:1852-1854.
11. Bannai S, Kitamura E. 1980. Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture. J Biol Chem 255:2372-2376.
12. Bannai S, Kitamura E. 1981. Role of proton dissociation in the transport of cystine and glutamate in human diploid fibroblasts in culture. J Biol Chem 256:5770-5772.
13. Bannai S, Sato H, Ishii T, Sugita Y. 1989. Induction of cystine transport activity in human fibroblasts by oxygen. J Biol Chem 264:18480-18484.
14. -. Pflugers Arch 442:286-296.
15. Bingle L, Brown NJ, Lewis CE. 2002. The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. J Pathol 196:254-265.
16. Bridges CC, Kekuda R, Wang H, Prasad PD, Mehta P, Huang W, Smith SB, Ganapathy V. 2001. Structure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 42:47-54.
17. - by human immunodeficiency virus type I transactivator protein tat in retinal pigment epithelium. Invest Ophthalmol Vis Sci 45:2906-2914.
18. - in the brain, kidney, and duodenum. J Histochem Cytochem 54:549-557.
19. Chase LA, Roon RJ, Wellman L, Beitz AJ, Koerner JF. 2001. L-Quisqualic acid transport into hippocampal neurons by a cystine-sensitive carrier is required for the induction of quisqualate sensitization. Neuroscience 106:287-301.
20. Chawla RK, Lewis FW, Kutner MH, Bate DM, Roy RG, Rudman D. 1984. Plasma cysteine, cystine, and glutathione in cirrhosis. Gastroenterology 87:770-776.
21. Chillaron J, Roca R, Valencia A, Zorzano A, Palacin M. 2001. Heteromeric amino acid transporters: Biochemistry, genetics, and physiology. Am J Physiol Renal Physiol 281:F995-1018.
22. Chintala S, Li W, Lamoreux ML, Ito S, Wakamatsu K, Sviderskaya EV, Bennett DC, Park YM, Gahl WA, Huizing M, Spritz RA, Ben S, Novak EK, Tan J, Swank RT. 2005. Slc7a11 gene controls production of pheomelanin pigment and proliferation of cultured cells. Proc Natl Acad Sci USA 102:10964-10969.
23. Cho Y, Bannai S. 1990. Uptake of glutamate and cysteine in C-6 glioma cells and in cultured astrocytes. J Neurochem 55:2091-2097.
24. Choi DW, 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634.
25. Christensen HN. 1990. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev 70:43-77.
26. Chung WJ, Lyons SA, Nelson GM, Hamza H, Gladson CL, Gillespie GY, Sontheimer H. 2005. Inhibition of cystine uptake disrupts the growth of primary brain tumors. J Neurosci 25:7101-7110.
27. Dai Z, Huang Y, Sadee W, Blower P. 2007. Chemoinformatics analysis identifies cytotoxic compounds susceptible to chemoresistance mediated by glutathione and cystine/ glutamate transport system xc. J Med Chem 50:1896-1906.
28. Dave MH, Schulz N, Zecevic M, Wagner CA, Verrey F. 2004. Expression of heteromeric amino acid transporters along the murine intestine. J Physiol 558:597-610.
29. Dhakshinamoorthy S, Jaiswal AK. 2002. c-Maf negatively regulates ARE-mediated detoxifying enzyme genes expression and anti-oxidant induction. Oncogene 21:5301-5312.
30. Dhakshinamoorthy S, Jain AK, Bloom DA, Jaiswal AK. 2005. Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants. J Biol Chem 280:16891-16900.
31. - and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes. J Immunol 178:6549-6556.
32. Doxsee DW, Gout PW, Kurita T, Lo M, Buckley AR, Wang Y, Xue H, Karp CM, Cutz JC, Cunha GR, Wang YZ. 2007. Sulfasalazine-induced cystine starvation: Potential use for prostate cancer therapy. Prostate 67:162-171.
33. Dringen R. 2000. Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649-671.
34. Dun Y, Mysona B, Van Ells T, Amarnath L, Shamsul Ola M, Ganapathy V, Smith SB. 2006. Expression of the cystine-glutamate exchanger (x(c) (-)) in retinal ganglion cells and regulation by nitric oxide and oxidative stress. Cell Tissue Res 324:189-202.
35. Eagle H, Washington C, Friedman SM. 1966. The synthesis of homocystine, cystathionine, and cystine by cultured diploid and heteroploid human cells. Proc Natl Acad Sci USA 56:156-163.
36. Eck HP, Droge W. 1989. Influence of the extracellular glutamate concentration on the intracellular cyst(e)ine concentration in macrophages and on the capacity to release cysteine. Biol Chem Hoppe Seyler 370:109-113.
37. Edinger AL, Thompson CB. 2002. Antigen-presenting cells control T cell proliferation by regulating amino acid availability. Proc Natl Acad Sci USA 99:1107-1109.
38. Espey MG, Kustova Y, Sei Y, Basile AS. 1998. Extracellular glutamate levels are chronically elevated in the brains of LP-BM5-infected mice: A mechanism of retrovirus-induced encephalopathy. J Neurochem 71:2079-2087.
39. Estrela JM, Ortega A, Obrador E. 2006. Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 43:143-181.
40. Fernandez E, Torrents D, Zorzano A, Palacin M, Chillaron J. 2005. Identification and functional characterization of a novel low affinity aromatic-preferring amino acid transporter (arpAT). One of the few proteins silenced during primate evolution. J Biol Chem 280:19364-19372.
41. Fernandez E, Jimenez-Vidal M, Calvo M, Zorzano A, Tebar F, Palacin M, Chillaron J. 2006. The structural and functional units of heteromeric amino acid transporters. The heavy subunit rBAT dictates oligomerization of the heteromeric amino acid transporters. J Biol Chem 281:26552-26561.
42. Filipits M, Pohl G, Rudas M, Dietze O, Lax S, Grill R, Pirker R, Zielinski CC, Hausmaninger H, Kubista E, Samonigg H, Jakesz R. 2005. Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: The Austrian Breast and Colorectal Cancer Study Group. J Clin Oncol 23:1161-1168.
43. - light subunit reveals a re-entrant loop with substrate-restricted accessibility. J Biol Chem 279:31228-31236.
44. Gmunder H, Eck HP, Benninghoff B, Roth S, Droge W. 1990. Macrophages regulate intracellular glutathione levels of lymphocytes. Evidence for an immunoregulatory role of cysteine. Cell Immunol 129:32-46.
45. Gmunder H, Eck HP, Droge W. 1991. Low membrane transport activity for cystine in resting and mitogenically stimulated human lymphocyte preparations and human T cell clones. Eur J Biochem 201:113-117.
46. Gochenauer GE, Robinson MB. 2001. Dibutyryl-cAMP (dbcAMP) up-regulates astrocytic chloride-dependent L-[3H]glutamate transport and expression of both system xc(-) subunits. J Neurochem 78:276-286.
47. Gout PW. 1987. Transient requirement for prolactin as a growth initiator following treatment of autonomous Nb2 node rat lymphoma cell cultures with butyrate. Cancer Res 47:1751-1755.
48. - transport system. Proc Ann 79th Mtg Endocrine Soc (Minneapolis). Abstract No. P3-16, p 440.
49. Gout PW, Beer CT, Noble RL. 1980. Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas. Cancer Res 40:2433-2436.
50. Gout PW, Horsman DE, Fox K, De Jong G, Ma S, Bruchovsky N. 1994. The rat Nb2 lymphoma: A novel model for tumor progression. Anticancer Res 14:2485-2492.
51. Gout PW, Kang YJ, Buckley DJ, Bruchovsky N, Buckley AR. 1997. Increased cystine uptake capability associated with malignant progression of Nb2 lymphoma cells. Leukemia 11:1329-1337.
52. Gout PW, Buckley AR, Simms CR, Bruchovsky N. 2001. Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: A new action for an old drug. Leukemia 15:1633-1640.
53. Gout PW, Simms CR, Robertson MC. 2003. In vitro studies on the lymphoma growth-inhibitory activity of sulfasalazine. Anticancer Drugs 14:21-29.
54. Griffith OW. 1999. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med 27:922-935.
55. Gupta V, Jani JP, Jacobs S, Levin M, Fields L, Awasthi S, Xu BH, Sreevardhan M, Awasthi YC, Singh SV. 1995. Activity of melphalan in combination with the glutathione transferase inhibitor sulfasalazine. Cancer Chemother Pharmacol 36:13-19.
56. Haimeur A, Deeley RG, Cole SP. 2002. Charged amino acids in the sixth transmembrane helix of multidrug resistance protein 1 (MRP1/ABCC1) are critical determinants of transport activity. J Biol Chem 277: 41326-41333.
57. Hishinuma I, Ishii T, Watanabe H, Bannai S. 1986. Mouse lymphoma L1210 cells acquire a new cystine transport activity upon adaptation in vitro. In Vitro Cell Dev Biol 22: 127-134.
58. Horsman DE, Masui S, Gout PW. 1991. Karyotypic changes associated with loss of prolactin dependency of rat Nb2 node lymphoma cell cultures. Cancer Res 51: 282-287.
59. Hosoya K, Tomi M, Ohtsuki S, Takanaga H, Saeki S, Kanai Y, Endou H, Naito M, Tsuruo T, Terasaki T. 2002. Enhancement of L-cystine transport activity and its relation to xCT gene induction at the blood-brain barrier by diethyl maleate treatment. J Pharmacol Exp Ther 302: 225-231.
60. Huang Y, Dai Z, Barbacioru C, Sadee W. 2005. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Res 65: 7446-7454.
61. Huang Y, Sadee W. 2006. Membrane transporters and channels in chemoresistance and - sensitivity of tumor cells. Cancer Lett 239: 168-182.
62. Iemata M, Takarada T, Hinoi E, Taniura H, Yoneda Y. 2007. Suppression by glutamate of proliferative activity through glutathione depletion mediated by the cystine/glutamate antiporter in mesenchymal C3H10T1/2 stem cells. J Cell Physiol 22:22.
63. Iglehart JK, York RM, Modest AP, Lazarus H, Livingston DM. 1977. Cystine requirement of continuous human lymphoid cell lines of normal and leukemic origin. J Biol Chem 252:7184-7191.
64. Ishii T, Bannai S, Sugita Y. 1981a. Mechanism of growth stimulation of L1210 cells by 2-mercaptoethanol in vitro. Role of the mixed disulfide of 2-mercaptoethanol and cysteine. J Biol Chem 256:12387-12392.
65. Ishii T, Hishinuma I, Bannai S, Sugita Y. 1981b. Mechanism of growth promotion of mouse lymphoma L1210 cells in vitro by feeder layer or 2-mercaptoethanol. J Cell Physiol 107:283-293.
66. Ishii T, Sato H, Miura K, Sagara J, Bannai S. 1992. Induction of cystine transport activity by stress. Ann N Y Acad Sci 663:497-498.
67. Jimenez-Vidal M, Gasol E, Zorzano A, Nunes V, Palacin M, Chillaron J. 2004. Thiol modification of cysteine 327 in the eighth transmembrane domain of the light subunit xCT of the heteromeric cystine/glutamate antiporter suggests close proximity to the substrate binding site/permeation pathway. J Biol Chem 279:11214-11221.
68. Kagami T, Wang Y, Tien A, Watahiki A, Lo M, Xue H, Gout PW, Wang YZ. 2007. Sulfasalazine enhances growth-inhibitory activity of doxorubicin: Potential use in combination chemotherapy of advanced prostate cancer. Proc 98th Ann Mtg Am Assoc Cancer Res (Los Angeles, CA), Late-breaking Abstract No. LB-322.
69. Kaleeba JA, Berger EA. 2006. Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: Cystine transporter xCT. Science 311:1921-1924.
70. Kanai Y, Hediger MA. 2004. The glutamate/neutral amino acid transporter family SL CI: Molecular, physiological and pharmacological aspects. Pflugers Arch 447:469-479.
71. Keating MJ, Holmes R, Lerner S, Ho DH. 1993. L-asparaginase and PEG asparaginase - Past. present, and future. Leuk Lymphoma 10:153-157.
72. Kim JY, Kanai Y, Chairoungdua A, Cha SH, Matsuo H, Kim DK, Inatomi J, Sawa H, Ida Y, Endou H. 2001. Human cystine/glutamate transporter: cDNA cloning and upregulation by oxidative stress in glioma cells. Biochim Biophys Acta 1512:335-344.
73. Koyama Y, Kimura Y, Hashimoto H, Matsuda T, Baba A. 2000. L-lactate inhibits L-cystine/L-glutamate exchange transport and decreases glutathione content in rat cultured astrocytes. J Neurosci Res 59:685-691.
74. La Bella V, Valentino F, Piccoli T, Piccoli F. 2007. Expression and developmental regulation of the cystine/glutamate exchanger (x (c) (-)) in the rat. Neurochem Res 32:1081-1090.
75. Lay JD, Hong CC, Huang JS, Yang YY, Pao CY, Liu CH, Lai YP, Lai GM, Cheng AL, Su IJ, Chuang SE. 2007. Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL. Cancer Res 67:3878-3887.
76. Lee JM, Johnson JA. 2004. An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol 37:139-143.
77. - protects from oxidative glutamate toxicity. J Neurochem 98:916-925.
78. Li H, Marshall ZM, Whorton AR. 1999. Stimulation of cystine uptake by nitric oxide: Regulation of endothelial cell glutathione levels. Am J Physiol 276:C803-811.
79. Li L, Lim J, Jacobs MD, Kistler J, Donaldson PJ. 2007. Regional differences in cystine accumulation point to a sutural delivery pathway to the lens core. Invest Ophthalmol Vis Sci 48:1253-1260.
80. Lim J, Lam YC, Kistler J, Donaldson PJ. 2005. Molecular characterization of the cystine/ glutamate exchanger and the excitatory amino acid transporters in the rat lens. Invest Ophthalmol Vis Sci 46:2869-2877.
81. Lim J, Lorentzen KA, Kistler J, Donaldson PJ. 2006. Molecular identification and characterisation of the glycine transporter (GLYT1) and the glutamine/glutamate transporter (ASCT2) in the rat lens. Exp Eye Res 83:447-455.
82. Lo M, Doxsee DW, Wang Y, Xue H, Ling V, Wang YZ, Gout PW. 2006. Sulfasalazine: Potential use of an old drug for treatment of pancreatic cancer. Proc 97th Ann Mtg Am Assoc Cancer Res (Washington, DC), Abstract No. 4705.
83. Lu L, Hope BT, Shaham Y. 2004. The cystine-glutamate transporter in the accumbens: A novel role in cocaine relapse. Trends Neurosci 27:74-76.
84. Lyons SA, Chung WJ, Weaver AK, Ogunrinu T, Sontheimer H. 2007. Autocrine glutamate signaling promotes glioma cell invasion. Cancer Res 67:9463-9471.
85. Maechler P, Wollheim CB. 1999. Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Nature 402:685-689.
86. Makowske M, Christensen HN. 1982. Contrasts in transport systems for anionic amino acids in hepatocytes and a hepatoma cell line HTC. J Biol Chem 257:5663-5670.
87. Mann GE, Niehueser-Saran J, Watson A, Gao L, Ishii T, de Winter P, Siow RC. 2007. Nrf2/ ARE regulated antioxidant gene expression in endothelial and smooth muscle cells in oxidative stress: Implications for atherosclerosis and preeclampsia. Sheng Li Xue Bao 59:117-127.
88. McBean GJ, Flynn J. 2001. Molecular mechanisms of cystine transport. Biochem Soc Trans 29:717-722.
89. Meldrum B, Garthwaite J. 1990. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11:379-387.
90. Meyer TE, Liang HQ, Buckley AR, Buckley DJ, Gout PW, Green EH, Bode AM. 1998. Changes in glutathione redox cycling and oxidative stress response in the malignant progression of Nb2 lymphoma cells. Int J Cancer 77:55-63.
91. Muerkoster S, Arlt A, Witt M, Gehrz A, Haye S, March C, Grohmann F, Wegehenkel K, Kalthoff H, Folsch UR, Schafer H. 2003. Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer. Int J Cancer 104:469-476.
92. Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT. 1989. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2:1547-1558.
93. Murphy TH, Schnaar RL, Coyle JT. 1990. Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. Faseb J 4:1624-1633.
94. - in immortalized rat brain endothelial cells. Toxicol Lett 155:289-296.
95. Narang VS, Pauletti GM, Gout PW, Buckley DJ, Buckley AR. 2003. Suppression of cystine uptake by sulfasalazine inhibits proliferation of human mammary carcinoma cells. Anticancer Res 23:4571-1580.
96. Narang VS, Pauletti GM, Gout PW, Buckley DJ, Buckley AR. 2007. Sulfasalazine-induced reduction of glutathione levels in breast cancer cells: Enhancement of growth-inhibitory activity of doxorubicin. Chemotherapy 53:210-217.
97. Oka A, Belliveau MJ, Rosenberg PA, Volpe JJ. 1993. Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanisms, and prevention. J Neurosci 13:1441-1453.
98. Okuno S, Sato H, Kuriyama-Matsumura K, Tamba M, Wang H, Sohda S, Hamada H, Yoshikawa H, Kondo T, Bannai S. 2003. Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines. Br J Cancer 88:951-956.
99. Palacin M, Bertran J, Zorzano A. 2000. Heteromeric amino acid transporters explain inherited aminoacidurias. Curr Opin Nephrol Hypertens 9:547-553.
100. Patel SA, Warren BA, Rhoderick JF, Bridges RJ. 2004. Differentiation of substrate and non-substrate inhibitors of transport system xc(-): An obligate exchanger of L-glutamate and L-cystine. Neuropharmacology 46:273-284.
101. - in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J Immunol 152:3578-3585.
102. Qiang W, Cahill JM, Liu J, Kuang X, Liu N, Scofield VL, Voorhees JR, Reid AJ, Yan M, Lynn WS, Wong PK. 2004. Activation of transcription factor Nrf-2 and its downstream targets in response to moloney murine leukemia virus ts1-induced thiol depletion and oxidative stress in astrocytes. J Virol 78:11926-11938.
103. - and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40. J Neurosci 26:3345-3356.
104. Rajan DP, Huang W, Kekuda R, George RL, Wang J, Conway SJ, Devoe LD, Leibach FH, Prasad PD, Ganapathy V. 2000. Differential influence of the 4F2 heavy chain and the protein related to b(0,+) amino acid transport on substrate affinity of the heteromeric b(0,+) amino acid transporter. J Biol Chem 275:14331-14335.
105. Rimaniol AC, Mialocq P, Clayette P, Dormont D, Gras G. 2001. Role of glutamate transporters in the regulation of glutathione levels in human macrophages. Am J Physiol Cell Physiol 281:C1964-1970.
106. Robe PA, Bentires-Alj M, Bonif M, Rogister B, Deprez M, Haddada H, Khac MT, Jolois O, Erkmen K, Merville MP, Black PM, Bours V. 2004. In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas. Clin Cancer Res 10:5595-5603.
107. Robe PA, Martin D, Albert A, Deprez M, Chariot A, Bours V. 2006. A phase 1-2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: Study protocol of [ISRCTN45828668]. BMC Cancer 6:29.
108. Rosado JO, Salvador M, Bonatto D. 2007. Importance of the trans-sulfuration pathway in cancer prevention and promotion. Mol Cell Biochem 301:1-12.
109. Saetre R, Rabenstein DL. 1978. Determination of cysteine in plasma and urine and homocysteine in plasma by high-pressure liquid chromatography. Anal Biochem 90:684-692.
110. Sagara J, Miura K, Bannai S. 1993. Cystine uptake and glutathione level in fetal brain cells in primary culture and in suspension. J Neurochem 61:1667-1671.
111. Sagara J, Makino N, Bannai S. 1996. Glutathione efflux from cultured astrocytes. J Neurochem 66:1876-1881.
112. Sakakura Y, Sato H, Shiiya A, Tamba M, Sagara J, Matsuda M, Okamura N, Makino N, Bannai S. 2007. Expression and function of cystine/glutamate transporter in neutrophils. J Leukoc Biol 81:974-982.
113. Sasaki H, Sato H, Kuriyama-Matsumura K, Sato K, Maebara K, Wang H, Tamba M, Itoh K, Yamamoto M, Bannai S. 2002. Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J Biol Chem 277:44765-44771.
114. Sato H, Fujiwara K, Sagara J, Bannai S. 1995. Induction of cystine transport activity in mouse peritoneal macrophages by bacterial lipopolysaccharide. Biochem J 310:547-551.
115. - and maintenance of intracellular glutathione levels in pancreatic acinar and islet cell lines. Biochim Biophys Acta 1414:85-94.
116. Sato H, Tamba M, Ishii T, Bannai S. 1999. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem 274:11455-11458.
117. Sato H, Tamba M, Kuriyama-Matsumura K, Okuno S, Bannai S. 2000. Molecular cloning and expression of human xCT, the light chain of amino acid transport system xc. Antioxid Redox Signal 2:665-671.
118. Sato H, Kuriyama-Matsumura K, Hashimoto T, Sasaki H, Wang H, Ishii T, Mann GE, Bannai S. 2001. Effect of oxygen on induction of the cystine transporter by bacterial lipopolysaccharide in mouse peritoneal macrophages. J Biol Chem 276:10407-10412.
119. Sato H, Tamba M, Okuno S, Sato K, Keino-Masu K, Masu M, Bannai S. 2002. Distribution of cystine/glutamate exchange transporter, system x(c)-, in the mouse brain. J Neurosci 22:8028-8033.
120. Sato H, Nomura S, Maebara K, Sato K, Tamba M, Bannai S. 2004. Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation. Biochem Biophys Res Commun 325:109-116.
121. Sato H, Shiiya A, Kimata M, Maebara K, Tamba M, Sakakura Y, Makino N, Sugiyama F, Yagami K, Moriguchi T, Takahashi S, Bannai S. 2005. Redox imbalance in cystine/glutamate transporter-deficient mice. J Biol Chem 280:37423-37429.
122. Schnelldorfer T, Gansauge S, Gansauge F, Schlosser S, Beger HG, Nussler AK. 2000. Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer 89:1440-1447.
123. Schubert D, Piasecki D. 2001. Oxidative glutamate toxicity can be a component of the excitotoxicity cascade. J Neurosci 21:7455-7462.
124. Schulz JB, Lindenau J, Seyfried J, Dichgans J. 2000. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267:4904-4911.
125. Shih AY, Johnson DA, Wong G, Kraft AD, Jiang L, Erb H, Johnson JA, Murphy TH. 2003. Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci 23:3394-3406.
126. Shih AY, Erb H, Sun X, Toda S, Kalivas PW, Murphy TH. 2006. Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. J Neurosci 26:10514-10523.
127. Sido B, Braunstein J, Breitkreutz R, Herfarth C, Meuer SC. 2000. Thiol-mediated redox regulation of intestinal lamina propria T lymphocytes. J Exp Med 192:907-912.
128. Sontheimer H. 2003. Malignant gliomas: Perverting glutamate and ion homeostasis for selective advantage. Trends Neurosci 26:543-549.
129. Sontheimer H, Nabors LB, Ye Z, Chung J. 2006. The role of glutamate in glioma growth. US NIH: SPOREs Specialized Programs of Research Excellence (www.cancer.gov).
130. c in cystine transport by a human pancreatic duct cell line. J Physiol 485:167-177.
131. Takano T, Lin JH, Arcuino G, Gao Q, Yang J, Nedergaard M. 2001. Glutamate release promotes growth of malignant gliomas. Nat Med 7:1010-1015.
132. Tanaka T, Shiu RPC, Gout PW, Beer CT, Noble RL, Friesen HG. 1980. A new, sensitive and specific bioassay for lactogenic hormones: Measurement of prolactin and growth hormone in human serum. J Clin Endocrinol Metab 51:1058-1063.
133. Tomi M, Hosoya K, Takanaga H, Ohtsuki S, Terasaki T. 2002. Induction of xCT gene expression and L-cystine transport activity by diethyl maleate at the inner blood-retinal barrier. Invest Ophthalmol Vis Sci 43:774-779.
134. -, in the newly developed rat retinal Muller cell line (TR-MUL). Glia 43:208-217.
135. Toohey JI. 1975. Sulfhydryl dependence in primary explant hematopoietic cells. Inhibition of growth in vitro with vitamin B12 compounds. Proc Natl Acad Sci USA 72:73-77.
136. Uchino H, Kanai Y, Kim do K, Wempe MF, Chairoungdua A, Morimoto E, Anders MW, Endou H. 2002. Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): Insights into the mechanisms of substrate recognition. Mol Pharmacol 61:729-737.
137. Uren JR, Lazarus H. 1979. L-cyst(e)ine requirements of malignant cells and progress toward depletion therapy. Cancer Treat Rep 63:1073-1079.
138. Vanhoefer U, Cao S, Minderman H, Toth K, Skenderis BS 2nd, Slovak ML, Rustum YM. 1996. d,l-Buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors. Clin Cancer Res 2:1961-1968.
139. Verrey F, Closs EI, Wagner CA, Palacin M, Endou H, Kanai Y. 2004. CATs and HATs: The SLC7 family of amino acid transporters. Pflugers Arch 447:532-542.
140. Wahl C, Liptay S, Adler G, Schmid RM. 1998. Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B. J Clin Invest 101:1163-1174.
141. Wakamatsu K, Ito S. 2002. Advanced chemical methods in melanin determination. Pigment Cell Res 15:174-183.
142. Wang XF, Cynader MS. 2000. Astrocytes provide cysteine to neurons by releasing glutathione. J Neurochem 74:1434-1442.
143. Wang H, Tamba M, Kimata M, Sakamoto K, Bannai S, Sato H. 2003. Expression of the activity of cystine/glutamate exchange transporter, system x(c)(-), by xCT and rBAT. Biochem Biophys Res Commun 305:611-618.
144. Wang L, Hinoi E, Takemori A, Nakamichi N, Yoneda Y. 2006. Glutamate inhibits chondral mineralization through apoptotic cell death mediated by retrograde operation of the cystine/glutamate antiporter. J Biol Chem 281:24553-24565.
145. Watanabe H, Bannai S. 1987. Induction of cystine transport activity in mouse peritoneal macrophages. J Exp Med 165:628-640.
146. Yadav S, Zajac E, Singhal SS, Awasthi S. 2007. Linking stress-signaling, glutathione metabolism, signaling pathways and xenobiotic transporters. Cancer Metastasis Rev 26:59-69.
147. Yang P, Ebbert JO, Sun Z, Weinshilboum RM. 2006. Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: A review. J Clin Oncol 24:1761-1769.
148. Ye ZC, Sontheimer H. 1999. Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 59:4383-4391.
149. Ye ZC, Rothstein JD, Sontheimer H. 1999. Compromised glutamate transport in human glioma cells: Reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. J Neurosci 19:10767-10777.
150. Zhang DD. 2006. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 38:769-789.
151. Zhu M, Bowden GT. 2004. Molecular mechanism(s) for UV-B irradiation-induced glutathione depletion in cultured human keratinocytes. Photochem Photobiol 80:191-196.